Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 1,834,800 shares, an increase of 10.5% from the August 15th total of 1,661,100 shares. Based on an average daily trading volume, of 5,263,800 shares, the short-interest ratio is currently 0.3 days.
Elite Pharmaceuticals Stock Performance
ELTP stock traded down $0.01 during midday trading on Wednesday, reaching $0.38. The stock had a trading volume of 1,393,660 shares, compared to its average volume of 1,253,772. The firm has a fifty day simple moving average of $0.23 and a two-hundred day simple moving average of $0.18. Elite Pharmaceuticals has a 52-week low of $0.08 and a 52-week high of $0.42. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.09 and a current ratio of 3.08. The stock has a market cap of $408.64 million, a PE ratio of 38.25 and a beta of 0.18.
Elite Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Elite Pharmaceuticals
- Short Selling: How to Short a Stock
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Stocks to Take Advantage of Rising Gold Prices
- How to Start Investing in Real Estate
- Smartsheet Is a Smart Buy for Traders and Investors: Here’s Why
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.